Bibliografia UJ CM

1/44
Catherine Thieblemont, Tycel Phillips, Herve Ghesquieres, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J. Lugtenburg.
Epcoritamab, a novel, subcutaneous CD3xCD20 bispecific T-cell-engaging antibody, in relapsed or refractory large B-cell lymphoma : dose expansion in a phase I/II trial
Journal of Clinical Oncology
2023 : Vo. 41, nr 12, s. 2238-2247, il., bibliogr. 26 poz., abstr.
Autor korespondencyjny: Catherine Thieblemont
Online First 2022-12-22
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
2/44
Tomas Jelinek, Renata Bezdekova, David Zihala, Tereza Sevcikova, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustova, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-Jose Garces, Noemi Puig, Maria-Teresa Cedena, Artur Jurczyszyn, Jorge J. Castillo, Miroslav Penka, Jakub Radocha, Maria Victoria Mateos, Jesus F. San-Miguel, Bruno Paiva, Ludek Pour, Lucie Rihova, Roman Hajek.
More than 2% of circulating tumor plasma cells defines plasma cell leukemia-like multiple myeloma
Journal of Clinical Oncology
2023 : Vol. 41, nr 7, s. 1383-1392, il., bibliogr., abstr.
Autor korespondencyjny: Roman Hajek
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0
Online First 2022-10-31
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
3/44
Michael L. Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S. Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S. Fenske, John F. Seymour, Andrew D. Zelenetz, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato, Nirav N. Shah.
Pirtobrutinib in covalent BTK-inhibitor pre-treated mantle cell lymphoma
Journal of Clinical Oncology
2023, il., bibliogr. 35 poz., sum.
Autor korespondencyjny: Michael L. Wang
Online First 2023-05-16
p-ISSN: 0732-183X
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
4/44
Isacco Montroni, Giampaolo Ugolini, Nicole M. Saur, Siri Rostoft, Antonino Spinelli, Barbara L. Van Leeuwen, Nicola De Liguori Carino, Federico Ghignone, Michael T. Jaklitsch, Jakub Kenig, Anna Garutti, Chiara Zingaretti, Flavia Foca, Bernadette Vertogen, Oriana Nanni, Steven D. Wexner, Riccardo A. Audisio.
Predicting functional recovery and quality of life in older patients undergoing colorectal cancer surgery : real-world data from the international GOSAFE Study
Journal of Clinical Oncology
2023, bibliogr., abstr.
Autor korespondencyjny: Flavia Foca
Online First 2023-06-30
p-ISSN: 0732-183X
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
5/44
Peter Hillmen, Barbara Eichhorst, Jennifer R. Brown, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Lugui Qiu, Maciej Kazmierczak, Keshu Zhou, Martin Simkovic, Jiri Mayer, Amanda Gillespie-Twardy, Mazyar Shadman, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Tommi Salmi, Meng Ji, Jessica Yecies, Adam Idoine, Kenneth Wu, Jane Huang, Wojciech Jurczak.
Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma : interim analysis of a randomized phase III trial.
Journal of Clinical Oncology
2023 : Vol. 41, nr 5, s. 1035-1045, il., bibliogr. 22 poz.
Autor korespondencyjny: Peter Hillmen
Online First 2022-11-17
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
6/44
Meletios A. Dimopoulos, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Bjorn E. Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Steven P. Treon, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam.
Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study
Journal of Clinical Oncology
2023, il., bibliogr. 16 poz., abstr.
Autor korespondencyjny: Meletios A. Dimopoulos
Online First 2023-07-21
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
7/44
John C. Byrd, Peter Hillmen, Paolo Ghia, Arnon P. Kater, Asher Chanan-Khan, Richard R. Furman, Susan O'Brien, Mustafa Nuri Yenerel, Arpad Illés, Neil Kay, Jose A. Garcia-Marco, Anthony Mato, Javier Pinilla-Ibarz, John F. Seymour, Stephane Lepretre, Stephan Stilgenbauer, Tadeusz Robak, Wayne Rothbaum, Raquel Izumi, Ahmed Hamdy, Priti Patel, Kara Higgins, Sophia Sohoni, Wojciech Jurczak.
Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia : results of the first randomized phase III trial.
Journal of Clinical Oncology
2021 : Vol. 39, nr 31, s. 3441-3452, il., bibliogr. 37 poz.
Autor korespondencyjny: John C. Byrd.
Open Access Creative Commons Attribution License CC-BY-NC ND 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
8/44
Peter Schmid, Seock-Ah Im, Anne Armstrong, Yeon Hee Park, Wei-Pang Chung, Zbigniew Nowecki, Simon Lord, Piotr Jan Wysocki, Yen-Shen Lu, Hannah Dry, Vatsala Karwe, Ross Stewart, Pia Herbolsheimer, Ana Tablante Nunes, Kyung Hae Jung.
BEGONIA : phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC) - Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd).
Journal of Clinical Oncology
2021 : Vol. 39, nr 15 suppl., abstr. 1023
2021 ASCO Annual Meeting I.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
SZZ
SIF
Adres url:
DOI:
9/44
James C. Glasbey.
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic : An International, Multicenter, Comparative Cohort Study.
Journal of Clinical Oncology
2021 : Vol. 39, nr 1, s. 66-78, il., bibliogr. 30 poz., abstr.
Autor korespondencyjny: Aneel Bhangu.
Publikacja wieloośrodkowa (brak nazwiska w polu autorskim).
COVIDSurg
p-ISSN: 0732-183X
AZ
IF: 50.739
Adres url:
Streszczenie w PubMed:
10/44
Angela Bellini, Ulrike Potschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, Jaydutt Bhalshankar, Nick Bown, Katleen de Preter, Nathalie Clement, Valerie Combaret, Jaime Font de Mora, Sally L. George, Irene Jimenez, Marta Jeison, Barbara Marques, Tommy Martinsson, Katia Mazzocco, Martina Morini, Annick Muhlethaler-Mottet, Rosa Noguera, Gaelle Pierron, Maria Rossing, Sabine Taschner-Mandl, Nadine Van Roy, Ales Vicha, Louis Chesler, Walentyna Balwierz, Victoria Castel, Martin Elliott, Per Kogner, Genevieve Laureys, Roberto Luksch, Josef Malis, Maja Popovic-Beck, Shifra Ash, Olivier Delattre, Dominique Valteau-Couanet, Deborah A. Tweddle, Ruth Ladenstein, Gudrun Schleiermacher.
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Journal of Clinical Oncology
2021 : Vol. 39, nr 30, s. 3377-3390, il., bibliogr. 56 poz., abstr.
Autor korespondencyjny: Gudrun Schleiermacher.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
11/44
Jorge E. Cortes, Jane Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey Howard Lipton, Charles Schiffer, James K. McCloskey, Andreas Hochhaus, Philippe H. Rousselot, Gianantonio Rosti, Hugues de Lavallade, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
OPTIC primary analysis : a dose-optimization study of 3 starting doses of ponatinib (PON).
Journal of Clinical Oncology
2021 : Vol. 39, nr 15 suppl., abstr. 7000
2021 ASCO Annual Meeting I.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
SZZ
SIF
Adres url:
DOI:
12/44
Piotr Jan Wysocki, Adam Ostrowski, Robert Segal, Pawel Potocki, Kamil Wladyslaw Konopka, Lukasz Kwinta, Lawrence Florin, Stephen Prince.
Preliminary data on antitumor activity of extracorporeal subtraction of soluble TNFRs to unleash the activity of endogenous TNFα combined with chemotherapy in treatment-refractory, advanced, triple-negative breast cancer patients.
Journal of Clinical Oncology
2021 : Vol. 39, nr 15 suppl., abstr. e13052
2021 ASCO Annual Meeting I.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
SZZ
SIF
Adres url:
13/44
Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Martin Elliott, Shifra Ash, Godfrey C.F. Chan, Genevieve Laureys, Maja Beck-Popovic, Kim Vettenranta, Walentyna Balwierz, Henrik Schroeder, Cormac Owens, Maja Cesen, Vassilios Papadakis, Toby Trahair, Gudrun Schleiermacher, Peter Ambros, Stefania Sorrentino, Andrew D.J. Pearson, Ruth Lydia Ladenstein.
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma : HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.
Journal of Clinical Oncology
2021 : Vol. 39, nr 23, s. 2552-2563
Autor korespondencyjny: Ruth Lydia Ladenstein.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
14/44
Grzegorz S. Nowakowski, Annalisa Chiappella, Randy D. Gascoyne, David W. Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Ozcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, Juan Miguel Bergua, Francesco Piazza, Heidi Mocikova, Anna Lia Molinari, Dok Hyun Yoon, Federica Cavallo, Monica Tani, Kazuhito Yamamoto, Koji Izutsu, Koji Kato, Myron Czuczman, Sarah Hersey, Adrian Kilcoyne, Jacqueline Russo, Krista Hudak, Jingshan Zhang, Steve Wade, Thomas E. Witzig, Umberto Vitolo.
ROBUST : A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology
2021 : Vol. 39, nr 12, s. 1317-1328, il., bibliog. 38 poz., abstr.
Autor korespondencyjny: Grzegorz S. Nowakowski.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
15/44
Nathan H. Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinśka-Posłuszny, Chan Y. Cheah, Tycel Phillips, Ewa Lech-Maranda, Bruce D. Cheson, Paolo F. Caimi, Sebastian Grosicki, Lori A. Leslie, Julio C. Chavez, Gustavo Fonseca, Sunil Babu, Daniel J. Hodson, Spencer H. Shao, John M. Burke, Jeff P. Sharman, Jennie Y. Law, John M. Pagel, Hari P. Miskin, Peter Sportelli, Owen A. O'Connor, Michael S. Weiss, Pier Luigi Zinzani.
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.
Journal of Clinical Oncology
2021 : Vol. 39, nr 15, s. 1609-1618, il., bibliogr. 40 poz., abstr.
Autor korespondencyjny: Pier Luigi Zinzani.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
16/44
Keith Holmes, Ulrike Potschger, Andrew D.J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas E. Matthyssens, Martin Metzelder, Tom Monclair, Jakob Stenman, Michal Rygl, Lars Rasmussen, Jean-Marc Joseph, Sabine Irtan, Stefano Avanzini, Jan Godzinski, Kristin Bjornland, Martin Elliott, Roberto Luksch, Victoria Castel, Shifra Ash, Walentyna Balwierz, Genevieve Laureys, Ellen Ruud, Vassilios Papadakis, Josef Malis, Cormac Owens, Henrik Schroeder, Maja Beck-Popovic, Toby Trahair, Ana Forjaz De Lacerda, Peter F. Ambros, Mark N. Gaze, Kieran McHugh, Dominique Valteau-Couanet, Ruth Lydia Ladenstein.
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma : A Report From the HR-NBL1/SIOPEN Study.
Journal of Clinical Oncology
2020 : Vol. 38, nr 25, s. 2902-2915
Autor korespondencyjny: Ruth Lydia Ladenstein.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 44.544
Adres url:
Streszczenie w PubMed:
DOI:
17/44
Ruth Lydia Ladenstein, Ulrike Poetschger, Dominique Valteau-Couanet, Juliet Gray, Roberto Luksch, Walentyna Balwierz, Victoria Castel, Shifra Ash, Maja Beck Popovic, Genevieve Laureys, Godfrey Chi-Fung Chan, Ellen Ruud, Kim Vettenranta, Cormac Owens, Henrik Schroeder, Peter F. Ambros, Sabine Sarnacki, Tom Boterberg, Holger N. Lode.
Risk factors in the HR-NBL-1/SIOPEN study in patients receiving dinutuximab beta (DB) based immunotherapy.
Journal of Clinical Oncology
2020 : Vol. 38, nr 15 suppl., abtr. 10536
2020 ASCO Annual Meeting I.
p-ISSN: 0732-183X
SZZ
SIF
Adres url:
18/44
Lydia Ruth Ladenstein, Ulrike Poetschger, Dominique Valteau-Couanet, Juliet Gray, Roberto Luksch, Walentyna Balwierz, Victoria Castel, Shifra Ash, Maja Beck Popovic, Genevieve Laureys, Godfrey Chi Fung Chan, Ellen Ruud, Kim Vettenranta, Cormac Owens, Henrik Schroeder, Hans Loibner, Peter F. Ambros, Sabine Sarnacki, Tom Boterberg, Holger N. Lode.
Randomization of dose-reduced subcutaneous interleukin-2 (scIL2) in maintenance immunotherapy (IT) with anti-GD2 antibody dinutuximab beta (DB) long-term infusion (LTI) in front-line high-risk neuroblastoma patients: Early results from the HR-NBL1/SIOPEN trial.
Journal of Clinical Oncology
2019 : Vol. 37, nr 15, suppl., abstr. 10013
2019 ASCO Annual Meeting I.
p-ISSN: 0732-183X
SZZ
SIF
19/44
Anas Younes, Laurie H. Sehn, Peter Johnson, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh, Sirpa Leppa, Shinya Rai, Mehmet Turgut, Wojciech Jurczak, Matthew C. Cheung, Ronit Gurion, Su-Peng Yeh, Andres Lopez-Hernandez, Ulrich Duhrsen, Catherine Thieblemont, Carlos Sergio Chiattone, Sriram Balasubramanian, Jodi Carey, Grace Liu, Martin Shreeve, Steven Sun, Sen Hong Zhuang, Jessica Vermeulen, Louis M. Staudt, Wyndham Wilson.
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology
2019 : Vol. 37, nr 15, s. 1285-1295, bibliogr., abstr.
Autor korespondencyjny: Anas Younes.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 32.956
Adres url:
Streszczenie w PubMed:
20/44
Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John Radford, Wojciech Jurczak, James Morton, Dolores Caballero, Sanjay Deshpande, Gary J. Gartenberg, Shean-sheng Wang, Rajendra N. Damle, Michael Schaffer, Sriram Balasubramanian, Jessica Vermeulen, Bruce D. Cheson, Gilles Salles.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Journal of Clinical Oncology
2018 : Vol. 36, nr 23, s. 2405-2412
Autor korespondencyjny: Ajay K. Gopal.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
21/44
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Peter Hillmen, John F. Seymour, Steven Coutre, Wojciech Jurczak, Stephen P. Mulligan, Anna Schuh, Sarit Assouline, Clemens-Martin Wendtner, Andrew W. Roberts, Matthew S. Davids, Johannes Bloehdorn, Talha Munir, Sebastian Bottcher, Lang Zhou, Ahmed Hamed Salem, Monali Desai, Brenda Chyla, Jennifer Arzt, Su Young Kim, Maria Verdugo, Gary Gordon, Michael Hallek, William G. Wierda.
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial .
Journal of Clinical Oncology
2018 : Vol. 36, nr 9, s. 1973-1980
Autor korespondencyjny: Stephan Stilgenbauer.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
22/44
Janina Markowska, Anna Markowska, Monika Szarszewska, Stefan Sajdak, Pawel Knapp, Anna Grybos, Anita Olejek, Wiesława Bednarek, Andrzej Marszalek, Ewa Markwitz, Robert Jach, Piotr Tomczak, Anita Monika Chudecka-Glaz, Rodryg Ramlau, Violetta Filas, Marian Grybos, Joanna Stanislawiak-Rudowicz, Karolina Jaszczyńska-Nowinka, Krystyna Adamska.
Do BRCA 1 mutations affect selected molecular variables in women with breast and ovarian cancer carrying cerebral metastases?
Journal of Clinical Oncology
2017 : Vol. 35, suppl., abstr. no. e13017.
2017 ASCO Annual Meeting, Chicago, 2-6 June 2017.
p-ISSN: 0732-183X
SZZ
SIF
Adres url:
23/44
Joanna Sulicka-Grodzicka, Andrzej Surdacki, Jaroslaw Krolczyk, Tomasz Grodzicki.
Cardiovascular risk factors in young adult survivors of childhood malignancies.
Journal of Clinical Oncology
2016 : Vol. 34, nr 3 suppl., abstr. 138.
Cancer Survivorship Symposium: Advancing Care and Research, San Francisco, United States, 15-16 January 2016.
p-ISSN: 0732-183X
SZZ
SIF
Adres url:
24/44
Ruth Ladenstein, Ulrike Poetschger, Martin Elliott, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck Popovic, Pavel Bician, Miklos Garami, Toby Trahair, Andrew D.J. Pearson, Dominique Valteau Couanet.
Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBIA/Siopen trial.
Journal of Clinical Oncology
2016 : Vol. 34, nr 15 suppl., abstr. 10527.
2016 ASCO Annual Meeting, Chicago, 3-7 June 2016.
p-ISSN: 0732-183X
SZZ
SIF
25/44
Michael Koller, EORTC Update Lung Cancer Module Group.
Update of the EORTC questionnaire for assessing quality of life in patients with lung cancer: Introducing the new EORTC QLQ-LC29.
Journal of Clinical Oncology
2016 : Vol. 34, nr 15 suppl., abstr. e18096
2016 ASCO Annual Meeting, Chicago, 3-7 June 2016.
p-ISSN: 0732-183X
SZZ
SIF
Adres url:
26/44
Owen A. O'Connor, Steven Horwitz, Tamas Masszi, Achiel Van Hoof, Peter Brown, Jeannette Doorduijn, Georg Hess, Wojciech Jurczak, Poul Knoblauch, Shanta Chawla, Gajanan Bhat, Mi Rim Choi, Jan Walewski, Kerry Savage, Francine Foss, Lee F. Allen, Andrei Shustov.
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.
Journal of Clinical Oncology
2015 : Vol. 32, nr 23, s. 2492-2499, il., bibliogr. 39 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 20.982
Adres url:
Streszczenie w PubMed:
27/44
Kim Klein, Gertjan Kaspers, Christine J. Harrison, H. Berna Beverloo, Ardine Reedijk, Mathilda Bongers, Jacqueline Cloos, Andrea Pession, Dirk Reinhardt, Martin Zimmerman, Ursula Creutzig, Michael Dworzak, Todd Alonzo, Donna Johnston, Betsy Hirsch Hirsch, Michal Zapotocky, Barbara De Moerloose, Alcira Fynn, Vinvent Lee, Takashi Taga, Akio Tawa, Anne Auvrignon, Bernward Zeller, Erik Forestier, Carmen Salgado, Walentyna Balwierz, Alexander Popa, Jeffrey Rubnitz, Susana Raimondi, Brenda Gibson.
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
Journal of Clinical Oncology
2015 : Vol. 33, nr 36, s. 4247-4258, il., bibliogr. 37 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 20.982
Adres url:
Streszczenie w PubMed:
28/44
Meletios A. Dimopoulos, Jens Hillengass, Saad Usmani, Elena Zamagni, Suzanne Lentzsch, Faith E. Davies, Noopur Raje, Orhan Sezer, Sonja Zweegman, Jatin Shah, Ashraf Badros, Kazuyuki Shimizu, Philippe Moreau, Chor-Sang Chim, Juan José Lahuerta, Jian Hou, Artur Jurczyszyn, Hartmut Goldschmidt, Pieter Sonneveld, Antonio Palumbo, Heinz Ludwig, Michele Cavo, Bart Barlogie, Kenneth Anderson, G. David Roodman, S. Vincent Rajkumar, Brian G.M. Durie, Evangelos Terpos.
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.
Journal of Clinical Oncology
2015 : Vol. 33, nr 6, s. 657-664
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 20.982
Streszczenie w PubMed:
29/44
Evangelos Terpos, Gareth Morgan, Meletios A. Dimopoulos, Matthew T. Drake, Suzanne Lentzsch, Noopur Raje, Orhan Sezer, Ramon Garcia-Sanz, Kazuyuki Shimizu, Ingemar Turesson, Tony Reiman, Artur Jurczyszyn, Giampaolo Merlini, Andrew Spencer, Xavier Leleu, Michele Cavo, Nikhil Munshi, S. Vincent Rajkumar, Brian G.M. Durie, G. David Roodman.
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Journal of Clinical Oncology
2013 : Vol. 31, nr 18, s. 2347-2357, bibliogr. 90 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 17.960
30/44
J[erzy] Holowiecki, S. Grosicki, S. Giebel, T. Robak, S[ławomira] Kyrcz-Krzemien, K. Kuliczkowski, A[leksander] B. Skotnicki, A. Hellmann, K. Sulek, A. Dmoszynska, J. Kloczko, W[iesław] W. Jedrzejczak, B. Zdziarska, K. Warzocha, K[rystyna] Zawilska, M. Komarnicki, M. Kielbinski, B[eata] Piatkowska-Jakubas, A. Wierzbowska, M. Wach, O. Haus.
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Journal of Clinical Oncology
2012 : Vol. 30, nr 20, s. 2441-2448, il., bibliogr. 41 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 18.038
DOI:
31/44
K[ajetana] Foryciarz, T[omasz] Sacha, Z[oriana] Salamanczuk, M. Jakobczyk, S. Czekalska, M. Zawada, M[arta] Szostek, I. Florek, A[leksander] B. Skotnicki.
Early intensification of imatinib treatment based on precise definition of accelerated phase in patients with chronic myeloid leukemia : Population-based analysis.
Journal of Clinical Oncology
2010 : Vol. 28, nr 15S part 1, abstr. 6588
ASCO Annual Meeting, Chicago, June 4-8, 2010.
SZZ
SIF
32/44
Ruth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, Isaac Yaniv, Victoria Castel, Genevieve Laureys, Josef Malis, Vassilios Papadakis, Ana Lacerda, Ellen Ruud, Per Kogner, Miklos Garami, Walentyna Balwierz, Henrik Schroeder, Maja Beck-Popovic, Gunter Schreier, David Machin, Ulrike Potschger, Andrew Pearson.
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma : the European HR-NBL1/SIOPEN study.
Journal of Clinical Oncology
2010 : Vol. 28, nr 21, s. 3516-3524, il., bibliogr. 55 poz.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 18.970
33/44
S. O'Brien, J.O. Moore, T.E. Boyd, L.M. Larratt, A[leksander] B. Skotnicki, B. Koziner, A.A. Chanan-Khan, J.F. Seymour, J. Gribben, L.M. Itri, K[anti] R. Rai.
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
Journal of Clinical Oncology
2009 : Vol. 27, nr 31, s. 5208-5212, bibliogr. 33 poz.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 17.793
34/44
Agnieszka Wozniak, P. Rutkowski, M. Debiec-Rychter, J. Siedlecki, W. Michej, C[zesław] Osuch, M[aciej] Matlok, W. Ruka, J. Limon, Polish Clinical GIST Registry.
Spectrum of KIT and PDGFRA mutations in primary gastrointestinal stromal tumors : Polish Clinical GIST Registry experience.
Journal of Clinical Oncology
2009 : Vol. 27, nr 15S, abstr. e21504
2009 ASCO Annual Meeting, Orlando, Florida, 2009.
SZZ
SIF
35/44
W[ojciech] Jurczak, A. Giza, D[orota] Krochmalczyk, M. Sobocinski, D[agmara] Zimowska-Curylo, B[eata] Stella-Holowiecka, P. Boguradzki, E. Kisiel, T[omasz] Wróbel, W[anda] Knopinska-Posluszny, A[leksander] B. Skotnicki.
Survival benefit of post induction consolidation therapy in MCL (mantle cell lymphoma) : A Polish Lymphoma Research Group (PLRG) retrospective multicenter analysis.
Journal of Clinical Oncology
2009 : Vol. 27, nr 15S, abstr. e19510
2009 ASCO Annual Meeting, Orlando, Florida, 2009.
SZZ
SIF
36/44
Antoaneta Tomova, Thomas Brodowicz, Valentina Tzekova, Constantin Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan [Janusz] Pawlęga, Stanislav Spanik, Moshe Inbar, Christoph C. Zielinski.
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine.
Journal of Clinical Oncology
2008 : Vol. 26, nr 15S, abstr. 1106
44th Annual Meeting of the American Society of Clinical Oncology, May 30-June 3, 2008, Chicago, IL, USA.
SZZ
SIF
37/44
D[orota] Krochmalczyk, W[ojciech] Jurczak, A. Giza, D[agmara] Zimowska-Curylo, M. Sobocinski, B. Malkowski, T. Pietrzak, J. Szefer, E. Senkus-Konefka, B. Kumiega, A[leksander] B. Skotnicki.
Early PET assessment and therapy de-escalation in patients with advanced Hodgkin's lymphoma treated with escalated BEACOPP regimen.
Journal of Clinical Oncology
2008 : Vol. 26, nr 15S, abstr. 8541
44th Annual Meeting of the American Society of Clinical Oncology, May 30-June 3, 2008, Chicago, IL, USA.
SZZ
SIF
38/44
Giuseppe Viale, Anita Giobbie-Hurder, Meredith M. Regan, Alan S. Coates, Mauro G. Mastropasqua, Patrizia Dell'Orto, Eugenio Maiorano, Gaetan MacGrogan, Stephen G. Braye, Christian Ohlschlegel, Patrick Neven, Zsolt Orosz, Wojciech P. Olszewski, Fiona Knox, Beat Thurlimann, Karen N. Price, Monica Castiglione-Gertsch, Richard D. Gelber, Barry A. Gusterson, Aron Goldhirsch, Breast International Group Trial 1-98.
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer : results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Journal of Clinical Oncology
2008 : Vol. 26, nr 34, s. 5569-5575, il., bibliogr. 28 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 17.157
39/44
P. Hillmen, A[leksander] B. Skotnicki, T. Robak, B. Jaksic, A. Dmoszynska, J. Wu, C. Sirard, J. Mayer.
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.
Journal of Clinical Oncology
2007 : Vol. 25, nr 35, s. 5616-5623.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 15.484
40/44
Susan O'Brien, Joseph O. Moore, Thomas E. Boyd, Loree M. Larratt, Aleksander Skotnicki, Benjamin Koziner, Asher A. Chanan-Khan, John F. Seymour, R. Gregory Bociek, Steve Pavletic, Kanti R. Rai.
Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of Clinical Oncology
2007 : Vol. 25, nr 9, s. 1114-1120, il., bibliogr., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 15.484
41/44
W[ojciech] Jurczak, St. Krochmalczyk, A. Giza, J[oanna] Węgrzyn, M. Sobocinski, J. Gawelko, J. Czyz, J[anusz] Pawlega, A[leksander] B. Skotnicki.
The choice of frist-line therapy in advanced Hodgkin lymphoma : Retrospective compromison of ABVD and escalated BEACOPP regimen.
Journal of Clinical Oncology
2007 : Vol. 25, nr 18S part 1 suppl., s. 456s., abstr. 8063
43rd Annual Meeting, Chicago, IL, June 1-5, 2007.
SZZ
SIF
42/44
Christoph Zielinski, Semir Beslija, Zrinka Mrsic-Krmpotic, Marzena Welnicka-Jaskiewicz, Christoph Wiltschke, Zsuzsanna Kahan, Mislav Grgic, Valentina Tzekova, Moshe Inbar, Jozika Cervek, Ivan Chernozemsky, Janos Szanto, Stanislav Spanik, Maria Wagnerova, Nicolae Ghilezan, Janusz Pawlega, Damir Vrbanec, Dmitry Khamtsov, Victoria Soldatenkova, Thomas Brodowicz.
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer : a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.
Journal of Clinical Oncology
2005 : Vol. 23, nr 7, s. 1401-1408, il., bibliogr. 26 poz., abstr.
AZ
ORG
AIF
IF: 11.810
43/44
I[wona] Chmielarczyk-Koszykowska, J[anusz] Pawlega.
The effect of treatment on the bone patients with Hodgkin's disease (hd).
Journal of Clinical Oncology
2004 : Vol. 22, nr 14S, s. 783, abstr. 8220
ASCO 40th Annual Meeting, New Orleans, LA, June 5-8, 2004.
SZZ
SIF
44/44
James Carmichael, Tadeusz Popiela, David Radstone, Stephen Falk, Markus Borner, Amit Oza, Torben Skovsgaard, Stephane Munier, Christophe Martin.
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Journal of Clinical Oncology
2002 : Vol. 20, nr 17, s. 3617-3627, il., bibliogr. 59 poz., abstr.
AZ
ORG
AIF
IF: 9.868
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ